Stock Groups

Pfizer raises Covid vaccine sales forecast to $36 billion for 2021

[ad_1]

This illustration, taken on October 31, 2020, shows a Pfizer logo and vials bearing a sticker that reads “COVID-19/ Coronavirus vaccine/ Injection only”.

Dado Ruvic | Reuters

PfizerOn Tuesday, Covid-19 raised its full-year revenue forecast by 7.5% to $36 Billion. It signed deals with other countries and received clearances to use its vaccines in children.

From the vaccine that it makes, sales were forecast at $33.5 billion in July. BioNTech

Pfizer’s Shot has become a top-selling product in its nearly 172-year-old history, thanks to a remarkable global vaccination campaign against Covid-19.

This company is well-known for its Viagra and Xanax drugs. It splits profits and expenses equally with its German counterpart.

Pfizer estimates that it will distribute 2.3 million doses of vaccines out of approximately 3 billion.

This is a developing story. Stay tuned for new updates.

[ad_2]